Work

S738 Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn’s Disease

Year: 2022

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000859592.38187.d3

Authors: Michael Kappelman, Sruthi Adimadhyam, Laura Hou, Andrew L. Simon, Angela Dobes, Lauren E. Parlett, Kevin Haynes, Mano Selvan, Qianli Ma, Vinit Nair, Jessica L. Burris, Jennifer E. Dorand, Millie Long

Institutions: University of North Carolina at Chapel Hill, Harvard University, Harvard Pilgrim Health Care, Crohn's and Colitis Foundation, Carelon Research (United States), Janssen Research & Development (United States), Humana (United States), Yale University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4316081895

Cites:

Cited by:

Related to: 10